• 1
    Aigner T, Stoss H, Weseloh G, et al. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B: Cell Pathol 1992; 62: 33745.
  • 2
    Bramlage LR, Schneider RK, Gabel AA. A clinical perspective on lameness orginating in the carpus. Equine Vet J 1988; 6(Suppl.): 128.
  • 3
    Di Cesare PE, Hauser N, Lehman D, et al. Cartilage oligomeric matrix protein (COMP) is an abundant component in tendon. FEBS Lett 1994; 354: 23740.
  • 4
    Di Cesare PE, Carlson CS, Stollerman ES, et al. Expression of cartilage oligomeric matrix protein by human synovium. FEBS Lett 1997; 412: 24952.
  • 5
    Dickinson SC, Vankemmelbeke MN, Buttle DJ, et al. Cleavage of cartilage oligomeric matrix protein (thrombospondin 5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Matrix Biol 2003; 22: 26778.
  • 6
    Ekman S, Reinholdt FP, Hultenby K, Heinegard D. Ultrastructural immunolocalisation of cartilage oligomeric matrix protein (COMP) in porcine growth cartilage. Calcified Tissue Int 1997; 60: 54753.
  • 7
    Fang C, Johnson D, Leslie MP, et al. Tissue distribution and measurement of cartilage oligomeric matrix protein in patients with magnetic resonance imaging-detected bone bruises after acute anterior cruciate ligament tears. J Orthop Res 2001; 19: 63441.
  • 8
    Frisbie DD, Ray CS, Ionescu M, et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation. Am J Res 1999; 60: 3069.
  • 9
    Genesis, version 2:12, Life science (UK) Ltd, 1995.
  • 10
    Heinegard D, Inerot S, Wieslander J, Lindblad G. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest 1985; 45: 4217.
  • 11
    Heinegard D, Sommarin Y. Isolation and characterization of proteoglycans. In: CunninghamLW, editor. Methods in enzy-mology: structural and contractile proteins Extracellular matrix. Orlando: Academic Press; 1987.
  • 12
    Johnston C, Roepstorff L, Drevemo S, Roneús N. Kinematics of the distal forelimb during the stance phase in fast trotting Standarbred. Equine Vet J 1995; 18(Suppl.): 1704.
  • 13
    Joosten LA, Helsen MM, Saxne T, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 1999; 163: 504955.
  • 14
    Joosten LA, Lubberts E, Helsen MM, et al. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1999; 1: 819.
  • 15
    Kawcak CE, McLlwraith CW, Norrdin RW, et al. The role of subchondral bone in joint disease: a review. Equine Vet J 2001; 33: 120.
  • 16
    Laemmli U. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 27: 6805.
  • 17
    Levick JR, Thompson PW. Intra-articular volume as an important factor governing macromolecular half life in synovial fluid. Ann Rheum Dis 1988; 47: 7012.
  • 18
    Lippiello L, Hall D, Mankin HJ. Collagen synthesis in normal and osteoarthritic cartilage. J Clin Invest 1977; 59: 593600.
  • 19
    Lohmander SL, Saxne T, Heinegard D. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994; 53: 813.
  • 20
    Lorenzo P. Altered pattern and synthesis of matrix macromolecules in early osteoarthritis. Metabolic labelling of cartilage explants (I). PhD Thesis, Identification and characterization of a novel cartilage gene product CILP, which is an early indicator of osteoarthritis. Lund University, Sweden, ISBN 91-628-3232-8, 1998.
  • 21
    Mankin HJ, Johnson ME, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules. J Bone Joint Surg Am 1981; 63: 1319.
  • 22
    Mansson B, Gulfe A, Geborek P, Heinegard D, Saxne T. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis 2001; 60: 2731.
  • 23
    McIlwraith CW. Diseases of joints, tendons, ligaments, and related structures. In: StashakTS, editor Adam's Lameness in horses. 5th ed. Lippincott Williams and Vilkins; 2002.
  • 24
    McIlwraith CW, Yovich JV, Martin GS. Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus. J Am Vet Med Assoc 1987; 5: 53140.
  • 25
    Misumi K, Vilim V, Clegg PD, et al. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluid. Osteoarthr Cartilage 2001; 9: 11927.
  • 26
    Misumi K, Vilim V, Hatazoe T, et al. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis. Equine Vet J 2002; 34: 6028.
  • 27
    Murray RC, Vedi S, Birch HL, et al. Subchondral bone thickness, hardness and remodelling are influenced by short-term exercise in a site-specific manner. J Orthop Res 2001; 19: 103542.
  • 28
    Morgelin M, Heinegard D, Engel J, Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five armed structure. J Biol Chem 1992; 267: 613741.
  • 29
    Norrdin RW, Kawcak CE, Capwell BA, McIlwraith CW. Subchondral bone failure in an equine model of overload arthrosis. Bone 1998; 22: 1339.
  • 30
    Oldberg A, Antonsson P, Lindblom K, Heinegard S. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992; 267: 2234650.
  • 31
    Palmer SE. Prevalence of carpal fractures in Thoroughbred and Standardbred racehorses. JAVMA 1986; 10: 11713.
  • 32
    Petersson IF, Boegard T, Svensson B, et al. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998; 1: 4650.
  • 33
    Pool RR. Pathologic manifestations of joint disease in the athletic horse. In: McIlwraithCW, TrotterGW, editors Joint disease in the horse. 5th ed. WB Saunders Company; 1996.
  • 34
    Rosenberg K, Olsson H, Mörgelin M, Heinegård D. COMP shows high affinity Zn-dependent interaction with triple helical collagen. J Biol Chem 1998; 273: 20397403.
  • 35
    Roux-Lombard P, Eberhardt K, Saxne T, et al. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study. Rheumatology 2001; 5: 54451.
  • 36
    Saxne T, Heinegärd D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheum 1992; 31: 58391.
  • 37
    Saxne T, Heinegard D. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 1992; 35: 38590.
  • 38
    Saxne T, Heinegård D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteglycan structures into the synovial fluid. Ann Rheum Dis 1986; 45: 4917.
  • 39
    Schneider RK, Bramlage AL, Gabel AA, et al. Incidence, location and classification of 371 third carpal bone fractures in 313 horses. Equine Vet J 1988; 6: 3342.
  • 40
    Shen Z, Heinegärd D, Sommarin Y. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol 1995; 14: 77381.
  • 41
    Skiöldebrand E, Heinegård D, Wong M, et al. Altered homeostasis of extracellular matrix proteins in articular cartilage of intensely training Standardbred trotter. In press.
  • 42
    Skiöldebrand E, Lorenzo P, Zunino L, et al. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein in synovial fluid from equine middle carpal joints. Equine Vet J 2001; 33: 394402.
  • 43
    Smith RK, Zunino L, Webbon PM, Heinegard D. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 1997; 16: 255.
  • 44
    Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthr Cartilage 2002; 10: 70713.
  • 45
    Wallis WJ, Simkin PA, Nelp WB. Intraarticular volume and clearance in human synovial effusions. Arthr Rheum 1985; 28: 4419.